GI Dynamics obtains $34.76M for EndoBarrier device

07/31/2013 | MedCityNews.com

GI Dynamics has secured about $34.76 million in financing and hopes to raise up to $17.75 million more. The company aims to use the money to finance a U.S. pivotal clinical study of its EndoBarrier Therapy as well as carry out its commercial strategy for the device worldwide, a spokesman for GI Dynamics said.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ